share_log

Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(6.8%),Peter Harwin(6.8%), etc.

Enliven Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Fairmount Funds Management LLC(6.8%),Peter Harwin(6.8%)等

美股SEC公告 ·  11/15 05:23
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息